Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,922.34 ($23.79) and traded as high as GBX 2,002.90 ($24.79). Hikma Pharmaceuticals shares last traded at GBX 2,002.90 ($24.79), with a volume of 103,513 shares.
Hikma Pharmaceuticals Stock Performance
The company’s 50-day moving average price is GBX 1,915.68 and its two-hundred day moving average price is GBX 1,922.73. The company has a market cap of £4.42 billion, a P/E ratio of 3,066.15, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.48.
About Hikma Pharmaceuticals
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Profitably Trade Stocks at 52-Week Highs
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- How to Effectively Use the MarketBeat Ratings Screener
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Are Penny Stocks a Good Fit for Your Portfolio?
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
